| Advances in the development of hybrid anticancer drugs S Fortin, G Bérubé Expert opinion on drug discovery 8 (8), 1029-1047, 2013 | 247 | 2013 |
| Bradykinin receptors: Agonists, antagonists, expression, signaling, and adaptation to sustained stimulation F Marceau, H Bachelard, J Bouthillier, JP Fortin, G Morissette, ... International immunopharmacology 82, 106305, 2020 | 106 | 2020 |
| Design, synthesis, biological evaluation, and structure–activity relationships of substituted phenyl 4-(2-oxoimidazolidin-1-yl) benzenesulfonates as new tubulin inhibitors … S Fortin, L Wei, E Moreau, J Lacroix, MF Côté, É Petitclerc, LP Kotra, ... Journal of medicinal chemistry 54 (13), 4559-4580, 2011 | 78 | 2011 |
| Quick and simple detection technique to assess the binding of antimicrotubule agents to the colchicine-binding site S Fortin, J Lacroix, MF Côté, E Moreau, É Petitclerc, R C-Gaudreault Biological procedures online 12, 113-117, 2010 | 69 | 2010 |
| Synthesis, antiproliferative activity and estrogen receptor α affinity of novel estradiol-linked platinum (II) complex analogs to carboplatin and oxaliplatin. Potential vector … P Saha, C Descôteaux, K Brasseur, S Fortin, V Leblanc, S Parent, ... European journal of medicinal chemistry 48, 385-390, 2012 | 59 | 2012 |
| Optimized N-phenyl-N′-(2-chloroethyl) ureas as potential antineoplastic agents: Synthesis and growth inhibition activity E Moreau, S Fortin, M Desjardins, JLC Rousseau, É Petitclerc, C René Bioorganic & medicinal chemistry 13 (24), 6703-6712, 2005 | 59 | 2005 |
| Stereoselective Synthesis of Fluorinated Galactopyranosides as Potential Molecular Probes for Galactophilic Proteins: Assessment of Monofluorogalactoside–LecA Interactions V Denavit, D Lainé, C Bouzriba, E Shanina, E Gillon, S Fortin, ... Chemistry–A European Journal 25 (17), 4478-4490, 2019 | 44 | 2019 |
| Substituted phenyl 4-(2-oxoimidazolidin-1-yl) benzenesulfonamides as antimitotics. Antiproliferative, antiangiogenic and antitumoral activity, and quantitative structure … S Fortin, L Wei, E Moreau, J Lacroix, MF Côté, É Petitclerc, LP Kotra, ... European journal of medicinal chemistry 46 (11), 5327-5342, 2011 | 44 | 2011 |
| Synthesis and crystal structure of a new isomer of the μ-oxo-bis [dichlorooxobis (pyridine) rhenium (V)] complex {OReCl2py2} 2O S Fortin, AL Beauchamp Inorganica chimica acta 279 (2), 159-164, 1998 | 41 | 1998 |
| New platinum (II) complexes conjugated at position 7α of 17β-acetyl-testosterone as new combi-molecules against prostate cancer: Design, synthesis, structure–activity … S Fortin, K Brasseur, N Morin, É Asselin, G Bérubé European Journal of Medicinal Chemistry 68, 433-443, 2013 | 40 | 2013 |
| A comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) of anthranilamide derivatives that are multidrug resistance modulators P Labrie, SP Maddaford, S Fortin, S Rakhit, LP Kotra, RC Gaudreault Journal of medicinal chemistry 49 (26), 7646-7660, 2006 | 40 | 2006 |
| N-Phenyl-N′-(2-chloroethyl)urea analogues of combretastatin A-4: Is the N-phenyl-N′-(2-chloroethyl)urea pharmacophore mimicking the trimethoxy phenyl … S Fortin, E Moreau, J Lacroix, JC Teulade, A Patenaude, C René Bioorganic & medicinal chemistry letters 17 (7), 2000-2004, 2007 | 33 | 2007 |
| N-Phenyl-N′-(2-chloroethyl)ureas (CEU) as potential antineoplastic agents. Part 2: Role of ω-hydroxyl group in the covalent binding to β-tubulin S Fortin, E Moreau, A Patenaude, M Desjardins, J Lacroix, JLC Rousseau, ... Bioorganic & medicinal chemistry 15 (3), 1430-1438, 2007 | 32 | 2007 |
| Effects of inactivation‐resistant agonists on the signalling, desensitization and down‐regulation of bradykinin B2 receptors MT Bawolak, S Fortin, J Bouthillier, A Adam, L Gera, R C.‐Gaudreault, ... British journal of pharmacology 158 (5), 1375-1386, 2009 | 30 | 2009 |
| N-Phenyl-N′-(2-chloroethyl)ureas (CEUs) as potential antineoplastic agents. Part 3: Role of carbonyl groups in the covalent binding to the colchicine-binding site E Moreau, S Fortin, J Lacroix, A Patenaude, JLC Rousseau, C René Bioorganic & medicinal chemistry 16 (3), 1206-1217, 2008 | 28 | 2008 |
| Neutral and cationic biimidazoledihalogenobis (trimethylphosphine) rhenium (iii) complexes: ion-pairing, acid–base and redox properties S Fortin, PL Fabre, M Dartiguenave, AL Beauchamp Journal of the Chemical Society, Dalton Transactions, 3520-3527, 2001 | 27 | 2001 |
| Synthesis, Biological Evaluation, and Structure–Activity Relationships of Novel Substituted N-Phenyl Ureidobenzenesulfonate Derivatives Blocking Cell Cycle … V Turcotte, S Fortin, F Vevey, Y Coulombe, J Lacroix, MF Cote, JY Masson, ... Journal of medicinal chemistry 55 (13), 6194-6208, 2012 | 26 | 2012 |
| Synthesis, antiproliferative activity evaluation and structure–activity relationships of novel aromatic urea and amide analogues of N-phenyl-N′-(2-chloroethyl) ureas S Fortin, E Moreau, J Lacroix, MF Côté, É Petitclerc, C René European journal of medicinal chemistry 45 (7), 2928-2937, 2010 | 26 | 2010 |
| Design, synthesis, cytocidal activity and estrogen receptor α affinity of doxorubicin conjugates at 16α-position of estrogen for site-specific treatment of estrogen receptor … P Saha, S Fortin, V Leblanc, S Parent, É Asselin, G Bérubé Steroids 77 (11), 1113-1122, 2012 | 25 | 2012 |
| Styryl-N-phenyl-N′-(2-chloroethyl) ureas and styrylphenylimidazolidin-2-ones as new potent microtubule-disrupting agents using combretastatin A-4 as model M Gagné-Boulet, S Fortin, J Lacroix, CA Lefebvre, MF Côté, C René European Journal of Medicinal Chemistry 100, 34-43, 2015 | 22 | 2015 |
